Bernhard C Danner
Overview
Explore the profile of Bernhard C Danner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
583
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tirilomi A, Tirilomis P, Elakad O, Yao S, Hinterthaner M, Danner B, et al.
Medicine (Baltimore)
. 2024 Oct;
103(40):e39911.
PMID: 39465762
Malignant tumors of the lung are the leading cancers worldwide. Prognostic biomarkers continue to be investigated for the detection and stratification of lung cancer for clinical use. In breast cancer...
2.
Fakuade F, Hubricht D, Moller V, Sobitov I, Liutkute A, Doring Y, et al.
Circulation
. 2024 Jun;
150(7):544-559.
PMID: 38910563
Background: Alterations in the buffering of intracellular Ca, for which myofilament proteins play a key role, have been shown to promote cardiac arrhythmia. It is interesting that although studies report...
3.
Gaudino M, Lemma M, Sandner S, Boening A, Harik L, Albert M, et al.
Eur J Cardiothorac Surg
. 2024 May;
65(5).
PMID: 38758192
No abstract available.
4.
Harnisch L, Brockmoller J, Hapke A, Sindern J, Bruns E, Evertz R, et al.
Pharmaceutics
. 2023 Nov;
15(11).
PMID: 38004576
(1) Background: In critically ill cardiac patients, parenteral and enteral food and drug administration routes may be used. However, it is not well known how drug absorption and metabolism are...
5.
Connolly S, Healey J, Belley-Cote E, Balasubramanian K, Paparella D, Brady K, et al.
Circulation
. 2023 Sep;
148(17):1298-1304.
PMID: 37732457
Background: LAAOS III (Left Atrial Appendage Occlusion Study III) showed that left atrial appendage (LAA) occlusion reduces the risk of ischemic stroke or systemic embolism in patients with atrial fibrillation...
6.
Tirilomi A, Elakad O, Yao S, Li Y, Hinterthaner M, Danner B, et al.
Medicine (Baltimore)
. 2023 Mar;
102(9):e33143.
PMID: 36862864
Among all cancer patient's lung cancer is the leading cause of death. Prognostic biomarkers continue to be investigated for the detection and stratification of lung cancer for clinical use. The...
7.
Evertz R, Hub S, Kowallick J, Seidler T, Danner B, Hasenfuss G, et al.
Sci Rep
. 2022 Dec;
12(1):21430.
PMID: 36509862
Transcatheter aortic valve replacement (TAVR) has become the standard treatment for aortic stenosis in older patients. It increasingly relies on accurate pre-procedural planning using multidetector computed tomography (MDCT). Since little...
8.
Li Y, Elakad O, Yao S, Von Hammerstein-Equord A, Hinterthaner M, Danner B, et al.
Metabolites
. 2022 Jul;
12(7).
PMID: 35888776
Activating KRAS mutations occur in about 30% of pulmonary adenocarcinoma (AC) cases and the discovery of specific inhibitors of G12C-mutated KRAS has considerably improved the prognosis for a subgroup of...
9.
Elakad O, Haupl B, Labitzky V, Yao S, Kuffer S, Von Hammerstein-Equord A, et al.
NPJ Precis Oncol
. 2022 Jul;
6(1):52.
PMID: 35853934
Lung cancer is the leading cause of cancer-related deaths worldwide. Fibroblast growth factor receptor 1 (FGFR1) gene amplification is one of the most prominent and potentially targetable genetic alterations in...
10.
Tirilomi A, Elakad O, Yao S, Li Y, Hinterthaner M, Danner B, et al.
Medicine (Baltimore)
. 2022 Feb;
101(6):e28814.
PMID: 35147120
Lung cancer remains the worldwide leading cause of cancer-related death. Currently, prognostic biomarkers for the detection and stratification of lung cancer are being investigated for clinical use. The surface protein...